Proxy Votes Now

Home › Funds › John Hancock › Small Cap Index Trust

Small Cap Index Trust (JAEWX) proxy voting record 2025-2026

Fund family: John Hancock · Filed by JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 756913) · SEC series S000008311

Share classes and tickers: JAEWX (C000022703), JAJOX (C000022705), JESIX (C000022704)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 13,986 with, 68 against, 767 abstentions (not counted as with management); 20 items carried no recommendation. Shareholder proposals: 17 FOR, 13 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with John Hancock as a whole

The same two figures as John Hancock’s manager page (290,519 ballot items across 99 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsJohn HancockItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)86.0%14,21690.1%242,172
Backed environmental and social shareholder proposals at US companiesn/a513.4%1,935

Where this fund voted differently from most John Hancock funds

Each ballot item this fund voted is set against the votes of the other John Hancock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most John Hancock funds on 25 items (0.3% of the 9,526 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost John Hancock fundsMgmtResult
MAREX GROUP PLC2026-05-21Special resolution - To approve certain matters in connection with the Scheme.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
MAREX GROUP PLC2026-05-21Special resolution - To approve certain matters in connection with the issuance of Marex Reissued Shares to New Marex.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
MAREX GROUP PLC2026-05-21Special resolution - To approve the Deferred Shares Reduction.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
MAREX GROUP PLC2026-05-21Special resolution - To approve the Scheme Reduction of Capital.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
MAREX GROUP PLC2026-05-21Special resolution - To approve the amendment of the Marex Articles.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
MAREX GROUP PLC2026-05-21To approve the Scheme made between the Company and the holders of Scheme Shares as set out in the Document.AgainstFOR — 4 of 5 John Hancock fundsAgainst—
GROUP 1 AUTOMOTIVE, INC.2026-05-12Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting.ForAGAINST — 5 of 7 John Hancock fundsAgainstNot approved, 25.3% support
CG ONCOLOGY, INC.2026-06-04To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Victor Tong, Jr.WithholdFOR — 4 of 6 John Hancock fundsAgainst—
ERASCA, INC.2026-06-26To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. CasdinWithholdFOR — 4 of 6 John Hancock fundsAgainst—
ERASCA, INC.2026-06-26To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D.WithholdFOR — 4 of 6 John Hancock fundsAgainst—
ERASCA, INC.2026-06-26To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D.WithholdFOR — 4 of 6 John Hancock fundsAgainst—
DYNE THERAPEUTICS, INC.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. David LubnerWithholdFOR — 4 of 6 John Hancock fundsAgainst—
DYNE THERAPEUTICS, INC.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Jason RhodesWithholdFOR — 4 of 6 John Hancock fundsAgainst—
APOGEE THERAPEUTICS, INC.2026-06-09DIRECTOR: William (BJ) Jones, Jr.AbstainFOR — 4 of 6 John Hancock fundsAgainst—
VAXCYTE, INC.2026-06-15DIRECTOR: Halley Gilbert, J.D.AbstainFOR — 5 of 9 John Hancock fundsAgainst—
VAXCYTE, INC.2026-06-15DIRECTOR: Olivier Brandicourt MDAbstainFOR — 5 of 9 John Hancock fundsAgainst—
KYMERA THERAPEUTICS, INC.2026-06-24DIRECTOR: Bruce Booth, D.Phil.AbstainFOR — 4 of 7 John Hancock fundsAgainst—
KYMERA THERAPEUTICS, INC.2026-06-24DIRECTOR: Elena Ridloff, CFAAbstainFOR — 4 of 7 John Hancock fundsAgainst—
KYMERA THERAPEUTICS, INC.2026-06-24DIRECTOR: John Maraganore, Ph.D.AbstainFOR — 4 of 7 John Hancock fundsAgainst—
KYMERA THERAPEUTICS, INC.2026-06-24DIRECTOR: Nello Mainolfi, Ph.D.AbstainFOR — 4 of 7 John Hancock fundsAgainst—
BLUE BIRD CORPORATION2026-03-11To approve an amendment to our certificate of incorporation to provide for limitation of liability of certain officers for certain breaches of fiduciary duty as permitted under Delaware law.ForAGAINST — 3 of 5 John Hancock fundsForApproved, 86.2% support
GLOBAL NET LEASE, INC.2026-05-21Election of Directors Edward M. Weil, Jr.ForWITHHOLD — 3 of 5 John Hancock fundsFor—
GLOBAL NET LEASE, INC.2026-05-21Election of Directors Robert I. KauffmanForWITHHOLD — 3 of 5 John Hancock fundsFor—
SELECT MEDICAL HOLDINGS CORPORATION2026-04-23Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold.AgainstFOR — 3 of 5 John Hancock fundsAgainst—
SELECT MEDICAL HOLDINGS CORPORATION2026-04-23Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting.ForAGAINST — 3 of 5 John Hancock fundsAgainstFailed (calculated), 20.0% support

Download all 25 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 14,821 such votes could be given a sector; the other 1,361 (9.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,06360.2%
Consumer Discretionary2,562341.3%
Health Care2,306110.5%
Industrials1,48950.3%
Technology1,33340.3%
Real Estate84110.1%
Energy58100.0%
Utilities38200.0%
Consumer Staples26662.3%
Basic Materials23400.0%
Miscellaneous21000.0%
Telecommunications19310.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,03525
Say-on-Pay1,7557
Audit-related1,7510
Compensation5122
Corporate Governance51118
Capital Structure2812
Extraordinary Transactions571
Other515
Shareholder Rights and Defenses483
Other Social Issues50

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
BLOOM ENERGY CORPORATIONMay 21, 2026$7M80
GUARDANT HEALTH, INC.June 17, 2026$3M50
GLAUKOS CORPORATIONMay 28, 2026$2M40
NEXTRACKER INC.August 18, 2025$2M50
BRIDGEBIO PHARMA, INC.June 22, 2026$2M70
THE ENSIGN GROUP, INC.May 13, 2026$2M60
AMERICAN HEALTHCARE REIT, INC.June 24, 2026$2M110
WATTS WATER TECHNOLOGIES, INC.May 19, 2026$2M110

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026SANMINA CORPORATIONTo consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 28, 2026THE BRINK'S COMPANYAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalForAgainst
May 13, 2026ICU MEDICAL, INC.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalForAgainst
May 21, 2026MERITAGE HOMES CORPORATIONShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalForAgainst
October 30, 2025CORE SCIENTIFIC, INC.Core Scientific's Merger Agreement ProposalAgainstFor
October 30, 2025CORE SCIENTIFIC, INC.Core Scientific's Advisory Compensation ProposalAgainstFor
May 20, 2026LUMEN TECHNOLOGIES, INC.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 4, 2026ASBURY AUTOMOTIVE GROUP, INC.Stockholder proposal regarding special stockholder meetings. Shareholder proposalForAgainst
December 15, 2025UNIFIRST CORPORATIONCOMPANY NOMINEE OPPOSED BY ENGINE: Joseph M. NowickiWithholdFor
December 15, 2025UNIFIRST CORPORATIONCOMPANY NOMINEE OPPOSED BY ENGINE: Steven S. SintrosWithholdFor
May 5, 2026SKYWEST, INC.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
May 12, 2026GROUP 1 AUTOMOTIVE, INC.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

15,014 ballot items at 1,926 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small Cap Index Trust (JAEWX) voted at 1,926 shareholder meetings of 1,819 companies, on 15,014 ballot items in all. Where management made a recommendation, the fund followed it on 94.4% of the items and voted against it 68 times. Its most frequent area of disagreement was director elections (25 of its votes against management). It voted on 30 shareholder proposals. It voted FOR the board's own proposals less often than John Hancock's funds as a whole (86.0% against 90.1%). It voted differently from most John Hancock funds on 25 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of John Hancock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.